Drugmakers Prep Medicare Pricing Suits for March to High Court

Major drugmakers have tailored a legal crusade against the Biden administration’s drug price negotiation program that legal scholars say appears strategically designed to reach the US Supreme Court.

Merck & Co., Bristol-Myers Squibb, Astellas Pharma, and Johnson & Johnson are among those engaging in the sweeping legal challenge. They’re joined by the US Chamber of Commerce and the Pharmaceutical Research and Manufacturers of America in filing separate lawsuits against the Biden administration’s Health and Human Services Department, alleging the Medicare drug-pricing negotiation program designed to lower costs for millions of beneficiaries and reduce the government’s spending on ...